Glaukos Corporation

LAGUNA HILLS, CA · CIK 0001192448 · Medtech · Public

Minimally invasive ophthalmic devices for glaucoma and retinal disease treatment

glaukos.com →
Grants
$200K
2 awards
Sector median: 1
Raised
$76M
5 Form D · Jan 2013
164 months since last filing
Contracts
$160K
9 awards · Veterans Affairs
#479 of 4531 in medtech
Patents
40
20 granted · 20 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Trabecular Bypass Stent and Applicator$100,000
Federal grantDepartment of Health and Human Services · Phase I · Development of a micropump for the glaucomatous eye$100,000
Private capital raisedForm D · SEC$6,000,392
Private capital raisedForm D · SEC$29,500,003
Private capital raisedForm D · SEC$4,500,000
Private capital raisedForm D · SEC$6,000,000
Private capital raisedForm D · SEC$30,000,002
Federal contract· 1 of 2 same dayDepartment of Veterans Affairs · Express Report: Implants$10,655
Federal contract· 2 of 2 same dayDepartment of Veterans Affairs · Express Report: Implants$10,655
Federal contractDepartment of Veterans Affairs · Pros Implants For Surgery$10,655
Federal contract· 1 of 3 same dayDepartment of Veterans Affairs · Left Eye Idose Isent$21,341
Federal contract· 2 of 3 same dayDepartment of Veterans Affairs · Right Eye Idose Isent$21,341
Federal contract· 3 of 3 same dayDepartment of Veterans Affairs · Prosthetics. Surgical Implant$21,341
Federal contractDepartment of Veterans Affairs · Nsc Surgical Implant Left Eye Idose Isent$21,341
Federal contractDepartment of Veterans Affairs · Prosthetics. Nsc Surgical Implant Left Eye Idose Isent$21,341
Federal contractDepartment of Veterans Affairs · Prosthetics. Surgical Implant Right Eye Idose Isent$21,341
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
476iRhythm Technologies, Inc.$163K$59M
477Coalesenz Inc.$163K—
478ProNova Solutions, LLC$161K$40M
479Glaukos Corporation$160K$76M
480Elucid Bioimaging Inc.$151K$116M
481ENDECTRA LLC$150K—
482SPECTRAL MOLECULAR IMAGING, INC.$150K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Olav BergheimDirector · Executive Officer
  • Thomas BurnsDirector · Executive Officer
  • Manish ChapekarDirector
  • Richard HarrisonExecutive Officer
  • Gilbert KlimanDirector
  • William LinkDirector
  • Paul MaderaDirector
  • Robert MoreDirector
  • Jonathan SilversteinDirector
  • Daniel TurnerDirector

Patents

USPTO · 20 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.